Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

The FDA approved a new Pfizer drug for hair loss in teens.

Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

New medications could improve treatment for severe alopecia areata in Australia.

Apremilast did not work for treating severe alopecia areata.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Clofazimine effectively treated ashy dermatosis in a patient.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.